Workflow
正海生物收盘上涨1.17%,滚动市盈率32.28倍,总市值39.02亿元

Core Viewpoint - Zhenghai Biological's stock closed at 21.68 yuan, with a PE ratio of 32.28, marking a new low in 75 days, and a total market value of 3.902 billion yuan [1] Company Summary - Zhenghai Biological specializes in the research, production, and sales of bio-regenerative materials, with key products including oral repair membranes, absorbable dura mater patches, bone repair materials, skin repair membranes, surgical packing sponges, self-etching adhesives, active biological bone, dura mater patches, phosphoric acid etchants, and dental pit and fissure sealants [1] - The company was recognized as one of the top 50 new material leading enterprises in Shandong Province for 2023 [1] Financial Performance - For Q1 2025, the company reported revenue of 97.4158 million yuan, a year-on-year increase of 8.68%, while net profit was 26.6267 million yuan, reflecting a year-on-year decrease of 34.06%, with a gross profit margin of 80.96% [1] Industry Summary - The average PE ratio for the medical device industry is 53.52, with a median of 37.14, placing Zhenghai Biological at the 67th position within the industry [1] - The industry average market value is 11.158 billion yuan, while the median is 5.172 billion yuan [2]